Journal ArticleDOI
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
Reads0
Chats0
About:
This article is published in European Heart Journal.The article was published on 1994-10-01. It has received 1177 citations till now. The article focuses on the topics: Framingham Risk Score.read more
Citations
More filters
Journal ArticleDOI
Prevalencia de fibrilación auricular y factores relacionados en una población del centro de Madrid
Francisco Javier Candel,M. Matesanz,F. Cogolludo,I. Candel,C. Mora,T. Bescos,M. Martín,I. Vila i Costa +7 more
TL;DR: Atrial fibrillation shows a prevalence and distribution in the studied area similar to that found in other European countries.
Journal ArticleDOI
Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008
José María Lobos Bejarano,Miguel Ángel Royo-Bordonada,Carlos Brotons,L. Álvarez-Sala,Pedro Armario,A. Maiques,D. Mauricio,Susana Sans,Fernando Jesús Antoñanzas Villar,Ángel Lizcano,A. Gil-Núñez,Fernando de Alvaro,Pedro Conthe,Emilio Luengo,Alfonso del Río,Olga Cortés,Ana de Santiago,M.A. Vargas,Mercedes Martínez,V. Lizarbe +19 more
TL;DR: The CEIPC Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008 as mentioned in this paper focuses on primary prevention and emphasizes the role of the nurses and primary care doctors in promoting a healthy life style, based on increasing physical activity, changing dietary habits, and not smoking.
Journal ArticleDOI
Comparison of two regimens of Policosanol administered at 20 mg/d in patients with type II hypercholesterolemia : A randomized, double-blind, placebo-controlled study
TL;DR: It is demonstrated that policosanol 20 mg/d is an effective and well-tolerated cholesterol-lowering regimen whether administered as a 20-mg tablet once daily or two 10-mg tablets once daily with the evening meal.
Journal ArticleDOI
Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence.
Jacek Budzyński,Janusz K. Rybakowski,Maciej Świątkowski,Lech Torliński,Maria Kłopocka,Wojciech Kosmowski,Marcin Ziółkowski +6 more
TL;DR: Naltrexone, by its hypolipaemic effect, could be useful for withdrawal therapy in alcoholic patients, because it may decrease the cardiovascular risk in abstinent patients with alcohol dependence by lipid mechanisms.
Journal ArticleDOI
Kardiovaskuläre Risikoschätzung für eine informierte Patientenentscheidung
Matthias Lenz,Ingrid Mühlhauser +1 more
TL;DR: The authors investigated whether currently available assessment tools for prediction of cardiovascular risk can be used for individual risk prediction as a basis of informed decision making.
Related Papers (5)
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more